Nomisma Healthcare

India

SupplySide West 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Dosage Form : Tablet

Grade : Oral, Parenteral

Brand Name : PLGA

Application : Controlled & Modified Release

Excipient Details : PLGA (Poly (Lactic-Co-Glycolic Acid)) is a unique base polymer for controlled release of drugs & medical implant materials. It is biodegradable & biocompatible and since both monomers occur naturally it has minimal toxicity.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45 Star Glucose, PLGA 65:35, PLGA 90:10.

Ingredient(s) : Poly DL Lactide co Glycolide

Dosage Form : Tablet

Grade : Oral, Parenteral

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Ingredient(s) : Poly DL Lactide co Glycolide

Dosage Form : Tablet

Category : Controlled & Modified Release

Brand : PLGA

Applications : PLGA (Poly (Lactic-Co-Glycolic Acid)) is a unique base polymer for controlled release of drugs & medical implant materials. It is biodegradable & biocompatible and since both monomers occur naturally it has minimal toxicity.

Pharmacopoeia Ref : NA

Technical Specs : Nano-particles, ultrapure, low-monomer & powder grades, available ratio PLGA 50:50, PLGA 75:25, PLGA 85:15, PLGA 55:45 Star Glucose, PLGA 65:35, PLGA 90:10.

Grade : Oral, Parenteral

Looking for Poly DL Lactide co Glycolide ? Find Controlled & Modified Release & other pharma excipients for Tablet dosage forms on PharmaCompass.

Filters

01

Nomisma Healthcare

Nomisma Healthcare